A detailed history of Fort Sheridan Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Fort Sheridan Advisors LLC holds 72,348 shares of PFE stock, worth $1.87 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
72,348
Previous 69,892 3.51%
Holding current value
$1.87 Million
Previous $1.96 Million 7.06%
% of portfolio
0.32%
Previous 0.32%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $68,031 - $77,093
2,456 Added 3.51%
72,348 $2.09 Million
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $36,046 - $42,239
1,427 Added 2.08%
69,892 $1.96 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $961,140 - $1.1 Million
-37,124 Reduced 35.16%
68,465 $1.9 Million
Q3 2023

Nov 08, 2023

SELL
$32.09 - $37.51 $166,129 - $194,189
-5,177 Reduced 4.67%
105,589 $3.5 Million
Q2 2023

Aug 01, 2023

BUY
$36.12 - $41.79 $233,515 - $270,172
6,465 Added 6.2%
110,766 $4.06 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $962,021 - $1.25 Million
24,423 Added 30.58%
104,301 $4.26 Million
Q4 2022

Feb 15, 2023

SELL
$41.75 - $54.5 $95,941 - $125,241
-2,298 Reduced 2.8%
79,878 $4.09 Million
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $71,066 - $86,754
1,624 Added 2.02%
82,176 $3.6 Million
Q2 2022

Aug 08, 2022

BUY
$46.53 - $55.17 $25,033 - $29,681
538 Added 0.67%
80,552 $4.22 Million
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $68,259 - $84,581
1,492 Added 1.9%
80,014 $4.14 Million
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $71,483 - $105,962
1,730 Added 2.25%
78,522 $4.64 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $91,334 - $117,327
2,327 Added 3.12%
76,792 $3.3 Million
Q2 2021

Aug 17, 2021

BUY
$35.91 - $40.68 $462,700 - $524,161
12,885 Added 20.92%
74,465 $2.92 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $591,533 - $667,131
17,663 Added 40.22%
61,580 $2.23 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $129,595 - $164,792
3,872 Added 9.67%
43,917 $1.62 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $228,631 - $268,237
7,201 Added 21.92%
40,045 $1.47 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $194,816 - $236,340
6,468 Added 24.52%
32,844 $1.07 Million
Q1 2020

May 12, 2020

BUY
$27.03 - $38.62 $268,380 - $383,457
9,929 Added 60.37%
26,376 $861,000
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $52,704 - $59,813
-1,601 Reduced 8.87%
16,447 $644,000
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $59,489 - $77,140
1,831 Added 11.29%
18,048 $648,000
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $68,154 - $76,521
1,843 Added 12.82%
16,217 $703,000
Q4 2018

May 13, 2019

BUY
$38.47 - $43.86 $552,967 - $630,443
14,374 New
14,374 $627,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Fort Sheridan Advisors LLC Portfolio

Follow Fort Sheridan Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Sheridan Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Sheridan Advisors LLC with notifications on news.